IP Library Granted Patent US 12,642,982
Granted Patent B2
US 12,642,982 · App. 17/933,710 · Granted Jun 2, 2026

Electrical optical medical lead

Inventor: Janardan Vaidyanathan (Thane, IN)
Assignee: Medtronic, Inc.
A61N5/01A61N5/0601A61N5/0622A61N2005/063A61N2005/0651
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,642,982
App. No.
17/933,710
Granted
Jun 2, 2026
Kind
B2
Abstract

An implantable medical system includes a light delivery module comprising a light source that generates light and a controller that controls the output of the light source, a lead with a plurality of electrodes, the lead extending from a proximal end to a distal end, wherein the lead further comprises an optical light guide configured to deliver the light from the light source, and the controller is configured to deliver voltage across two or more of the electrodes to steer a distal end of the optical light guide, to provide electrical stimulation or sense/record electrical signals.

Claims (28)

1 . An implantable medical system comprising:

a light delivery module comprising a light source that generates light and a controller that controls an output of the light source; and

a lead with a plurality of electrodes, the lead extending from a proximal end to a distal end,

wherein the lead further comprises an optical light guide configured to deliver the light from the light source, wherein the optical light guide comprises a property of being affected by a magnetic field, and

the controller is configured to deliver voltage across two or more of the electrodes to steer a distal end of the optical light guide.

2 . The implantable medical system of claim 1 , wherein the optical light guide comprises an optical fiber optically connected to the light source.

3 . The implantable medical system of claim 1 , further comprising a metallic material at or near the distal end of the optical light guide, wherein the controller is configured to deliver the voltage across two or more electrodes to generate a magnetic field that acts on the metallic material to steer the distal end of the optical light guide.

4 . The implantable medical system of claim 3 , wherein the metallic material comprises a metallic coating disposed on the distal end of the optical light guide.

5 . The implantable medical system of claim 3 , wherein the metallic material comprises a nanofluid disposed on the distal end of the optical light guide.

6 . The implantable medical system of claim 5 , wherein the nanofluid comprises iron oxide nanoparticles.

7 . The implantable medical system of claim 6 , wherein the iron oxide nanoparticles comprise Fe3O4.

8 . The implantable medical system of claim 1 , wherein at least one of the plurality of electrodes is a segmented electrode.

9 . The implantable medical system of claim 1 , wherein at least one of the plurality of electrodes is a ring electrode.

10 . The implantable medical system of claim 1 , wherein the optical light guide is a single-fiber optical light guide.

11 . The implantable medical system of claim 1 , wherein the optical light guide is a multi-fiber optical light guide.

12 . The implantable medical system of claim 1 , wherein the light source comprises one or more light emitting diodes (LEDs) or one or more quantum dots (QDs).

13 . The implantable medical system of claim 1 , wherein the light is selected to optically stimulate a target tissue and provide therapy.

14 . The implantable medical system of claim 1 , further comprising electrical stimulation circuitry configured to generate electrical stimulation for delivery via one or more of the plurality of electrodes.

15 . The implantable medical system of claim 1 , further comprising electrical sensing circuitry configured to sense electrical signals via one or more of the plurality of electrodes.

16 . The implantable medical system of claim 1 , wherein the controller is configured to deliver voltage across two or more selected electrodes of the plurality of electrodes to selectively steer the distal end of the optical light guide in different directions.

17 . A method comprising:

controlling delivery of voltage across electrodes of a lead to steer a distal end of an optical light guide of the lead, wherein the optical light guide comprises a property of being affected by a magnetic field; and

transmitting light from a light source of an implantable medical system to a patient via the optical light guide of the lead.

18 . The method of claim 17 , wherein the optical light guide comprises a metallic material at or near the distal end of the optical light guide, wherein a controller is configured to deliver the voltage across two or more electrodes to generate a magnetic field that acts on the metallic material to steer the distal end of the optical light guide.

19 . The method of claim 18 , wherein the metallic material comprises a metallic coating disposed on the distal end of the optical light guide.

20 . The method of claim 18 , wherein the metallic material comprises a nanofluid.

21 . The method of claim 18 , wherein controlling delivery of the voltage comprises:

controlling delivery of voltage across two or more selected electrodes of the electrodes to selectively steer the distal end of the optical light guide in different directions.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2022
From: VAIDYANATHAN, JANARDAN
To: INDIA MEDTRONIC PRIVATE LIMITED
Reel/Frame 061339/0984 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2022
From: VAIDYANATHAN, JANARDAN
To: INDIA MEDTRONIC PRIVATE LIMITED
Reel/Frame 061340/0087 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2022
From: INDIA MEDTRONIC PRIVATE LIMITED
To: MEDTRONIC, INC.
Reel/Frame 061340/0200 →
Continuity (2)
Provisional Application 63246106 · Sep 20, 2021
Related Publication 20230096373A1 · Mar 30, 2023
References Cited (20)
US 5334207A · Gay, Jr. · 1994 [cited by examiner]
US 7883536B1 · Bendett et al. · 2011 [cited by applicant]
US 8498699B2 · Wells et al. · 2013 [cited by applicant]
US 8632577B1 · Bendett et al. · 2014 [cited by applicant]
US 8864806B2 · Wells et al. · 2014 [cited by applicant]
US 10046174B2 · Deisseroth et al. · 2018 [cited by applicant]
US 10702697B2 · Chabrol · 2020 [cited by examiner]
US 10716942B2 · Zhang · 2020 [cited by applicant]
US 20050247472A1 · Helfer et al. · 2005 [cited by applicant]
US 20110125077A1 · Denison et al. · 2011 [cited by applicant]
US 20110125078A1 · Denison et al. · 2011 [cited by applicant]
US 20120253261A1 · Poletto et al. · 2012 [cited by applicant]
US 20120290025A1 · Keimel · 2012 [cited by applicant]
US 20130317573A1 · Zhu · 2013 [cited by examiner]
US 20150306414A1 · Nielsen et al. · 2015 [cited by applicant]
US 20150306415A1 · Tischendorf et al. · 2015 [cited by applicant]
US 20150375006A1 · Denison et al. · 2015 [cited by applicant]
US 20190201709A1 · Tischendorf et al. · 2019 [cited by applicant]
US 20210059779A1 · Zhao et al. · 2021 [cited by applicant]
US 20250090860A1 · Tsukamoto · 2025 [cited by examiner]